GREENLAND MINES LTD Current Assets
GREENLAND MINES LTD (GRML) had Current Assets of $12.21 million as of 2026-06-30, per its 10-Q filed 2026-08-17.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-17
- 2026-06-30: Assets, Current $12.21M.
- 2026-03-31: Assets, Current $10.93M.
- 2025-12-31: Assets, Current $7.29M.
- 2025-09-30: Assets, Current $7.77M.
| Period end | Assets, Current | Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $12.21M 10-Q · filed 2026-08-17 | |
| 2026-03-31 | $10.93M 10-Q/A · filed 2026-08-14 | |
| 2025-12-31 | $7.29M 10-Q · filed 2026-08-17 | |
| 2025-09-30 | $7.77M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $8.55M 10-Q · filed 2025-08-18 | |
| 2025-03-31 | $687.71K 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $157.81K 10-K/A · filed 2026-08-14 | |
| 2024-09-30 | $154.65K 10-Q · filed 2024-11-19 | |
| 2024-06-30 | $999.84K 10-Q · filed 2024-08-19 | |
| 2024-03-31 | $8.05K 10-Q · filed 2024-05-23 | |
| 2023-12-31 | $6.65K 10-K · filed 2025-03-31 | $199.53K 10-K · filed 2024-04-17 |
| 2023-09-30 | $203.81K 10-Q · filed 2023-11-17 | |
| 2023-06-30 | $258.92K 10-Q · filed 2023-08-21 | |
| 2023-03-31 | $340.06K 10-Q · filed 2023-05-24 | |
| 2022-12-31 | $440.16K 10-K · filed 2024-04-17 | |
| 2022-09-30 | $555.13K 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $665.55K 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $256.93K 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $4.95K 10-K/A · filed 2023-10-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |